Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients
Status:
Completed
Trial end date:
2016-12-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how well adolescent kidney transplant patients
tolerate a single dose of belatacept they receive at least 6 months after transplant surgery,
and how their body handles the drug.